Indeed, a peptide has been designed based on PTEN’s C-terminal sequence that can block this PTEN/PSD-95 interaction and it has been successfully tested in AD model mice (Knafo et al., 2016). The gene discussed is DLG4; the disease is Alzheimer disease.